Approved for VELSIPITY is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.. Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity to S1P receptors 1, 4, and 5 (S1P 1,4,5 ). Etrasimod has minimal activity on S1P 3 (25-fold lower than C… Side effects, costs, interactions, manufacturer, and generic alternatives…
Loading full data from Know Your Drugs Institute…